Does DABIGATRAN ETEXILATE Cause Procoagulant therapy? 737 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 737 reports of Procoagulant therapy have been filed in association with DABIGATRAN ETEXILATE (dabigatran etexilate). This represents 2.0% of all adverse event reports for DABIGATRAN ETEXILATE.
737
Reports of Procoagulant therapy with DABIGATRAN ETEXILATE
2.0%
of all DABIGATRAN ETEXILATE reports
4
Deaths
621
Hospitalizations
How Dangerous Is Procoagulant therapy From DABIGATRAN ETEXILATE?
Of the 737 reports, 4 (0.5%) resulted in death, 621 (84.3%) required hospitalization, and 4 (0.5%) were considered life-threatening.
Is Procoagulant therapy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DABIGATRAN ETEXILATE. However, 737 reports have been filed with the FAERS database.
What Other Side Effects Does DABIGATRAN ETEXILATE Cause?
Gastrointestinal haemorrhage (4,081)
Cerebrovascular accident (2,175)
Fall (1,786)
Ischaemic stroke (1,581)
Anaemia (1,412)
Haemorrhage (1,324)
Death (1,025)
Rectal haemorrhage (964)
Cerebral haemorrhage (946)
Upper gastrointestinal haemorrhage (861)
What Other Drugs Cause Procoagulant therapy?
Which DABIGATRAN ETEXILATE Alternatives Have Lower Procoagulant therapy Risk?
DABIGATRAN ETEXILATE vs DABRAFENIB
DABIGATRAN ETEXILATE vs DABRAFENIB\TRAMETINIB
DABIGATRAN ETEXILATE vs DACARBAZINE
DABIGATRAN ETEXILATE vs DACLATASVIR
DABIGATRAN ETEXILATE vs DACLIZUMAB